A BuiltForAI Property
Live data · NADAC + Part D CY24 · reviewed daily

Dutasteride and Tamsulosin (Jalyn)

5-alpha Reductase Inhibitor class · 3 generic manufacturers · 3 ANDAs filed at FDA.

First FDA approval2015-11-18
Generic availableYes · 3 mfrs
Shortage statusNone
340B exposureunknown
Last updated
NADAC: weekly (every Wed)Part D Formulary: quarterlyPart D Spend: annual (CY24)Orange Book: weeklyShortages: daily
At a glance · the numbers a plan sponsor wants on screen one
Lowest NADAC
$2.02/unit
6 NDCs benchmarked, lowest of all strengths.
Average NADAC
$2.02
Across all dosage forms in distribution.
Highest NADAC
$2.02
Range is tight.
Plans with PA
0 / 329
Zero PA friction — switching is purely formulary.

Questions a plan sponsor actually asks.

FAQPage schema10 entries indexed · 4 visible
What is Dutasteride and Tamsulosin used for?

Dutasteride and Tamsulosin is a 5-alpha Reductase Inhibitor medication tracked in Medicare Part D.

Is there a generic for Dutasteride and Tamsulosin?

Yes. 3 ANDAs filed at FDA, 3 generic manufacturers currently shipping.

How much does my plan pay for Dutasteride and Tamsulosin?

Across 329 Part D plans, Dutasteride and Tamsulosin averages $2.02/unit (NADAC). Lowest available: $2.02/unit. Highest in distribution: $2.02/unit.

Is Dutasteride and Tamsulosin on the FDA shortage list?

No. Dutasteride and Tamsulosin is not currently on the FDA Drug Shortage Database.

6 additional drug-specific questions are indexed in the page's FAQPage schema for search engines and LLM crawlers, beyond what renders visually above. View page source for the complete JSON-LD.

Same class. Different math.

5-alpha Reductase Inhibitor3 alternatives in D1
01
Dutasteride
Brand: AVODART
$0.172Lowest NADAC
10Generic mfrs
$55.0MCY24 Part D spend
Compare →
02
Dutasteride and Tamsulosin Hydrochloride Capsules
Brand: Dutasteride and Tamsulosin Hydrochloride
Lowest NADAC
0Generic mfrs
CY24 Part D spend
Compare →
03
Finasteride
Brand: PROPECIA
$0.041Lowest NADAC
9Generic mfrs
$144.5MCY24 Part D spend
Compare →

Sources · every number above traces back.

Last refresh30 May 2026

Drug identity, dosage forms, brand names: openFDA NDC Directory · First approval, ANDA history: FDA Orange Book (4 approvals on file) · NADAC unit costs: CMS NADAC weekly file (6 NDCs benchmarked) · Formulary tier and PA placement: CMS Part D Formulary file (329 plans) · Annualized spend, claims, beneficiaries: CMS Part D Spending Dashboard · Shortage status: FDA Drug Shortage Database · 340B exposure: HRSA OPAIS. Methodology and reproducibility notes on /methodology.